The 36-month beta value for GKOS is also noteworthy at 1.06. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 5 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for GKOS is 48.38M, and at present, short sellers hold a 5.01% of that float. The average trading volume of GKOS on August 01, 2024 was 516.87K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GKOS) stock’s latest price update
Glaukos Corporation (NYSE: GKOS)’s stock price has plunge by -2.99relation to previous closing price of 117.17. Nevertheless, the company has seen a -3.38% plunge in its stock price over the last five trading sessions. zacks.com reported 2024-08-01 that Glaukos’ (GKOS) second-quarter 2024 results showcase growth in revenues on the back of strong adoption of its glaucoma products like iStent and iDose TR. Loss at the operating level raises concern.
GKOS’s Market Performance
GKOS’s stock has fallen by -3.38% in the past week, with a monthly drop of -4.46% and a quarterly rise of 14.92%. The volatility ratio for the week is 3.95% while the volatility levels for the last 30 days are 3.52% for Glaukos Corporation The simple moving average for the last 20 days is -6.26% for GKOS stock, with a simple moving average of 23.14% for the last 200 days.
Analysts’ Opinion of GKOS
Many brokerage firms have already submitted their reports for GKOS stocks, with Citigroup repeating the rating for GKOS by listing it as a “Neutral.” The predicted price for GKOS in the upcoming period, according to Citigroup is $132 based on the research report published on July 10, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see GKOS reach a price target of $125, previously predicting the price at $84. The rating they have provided for GKOS stocks is “Buy” according to the report published on May 06th, 2024.
JP Morgan gave a rating of “Overweight” to GKOS, setting the target price at $91 in the report published on December 21st of the previous year.
GKOS Trading at -2.14% from the 50-Day Moving Average
After a stumble in the market that brought GKOS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.47% of loss for the given period.
Volatility was left at 3.52%, however, over the last 30 days, the volatility rate increased by 3.95%, as shares sank -7.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.30% upper at present.
During the last 5 trading sessions, GKOS fell by -5.92%, which changed the moving average for the period of 200-days by +68.76% in comparison to the 20-day moving average, which settled at $120.83. In addition, Glaukos Corporation saw 43.00% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GKOS starting from Gilliam Joseph E, who sale 2,250 shares at the price of $121.39 back on Jul 05 ’24. After this action, Gilliam Joseph E now owns 101,845 shares of Glaukos Corporation, valued at $273,128 using the latest closing price.
Gilliam Joseph E, the PRESIDENT & COO of Glaukos Corporation, sale 2,500 shares at $113.50 during a trade that took place back on Jun 03 ’24, which means that Gilliam Joseph E is holding 101,845 shares at $283,751 based on the most recent closing price.
Stock Fundamentals for GKOS
Current profitability levels for the company are sitting at:
- -0.38 for the present operating margin
- 0.76 for the gross margin
The net margin for Glaukos Corporation stands at -0.43. The total capital return value is set at -0.14. Equity return is now at value -29.37, with -14.78 for asset returns.
Based on Glaukos Corporation (GKOS), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at -0.21. The debt to equity ratio resting at 0.63. The interest coverage ratio of the stock is -9.0.
Currently, EBITDA for the company is -82.12 million with net debt to EBITDA at -3.8. When we switch over and look at the enterprise to sales, we see a ratio of 18.79. The receivables turnover for the company is 7.01for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.38.
Conclusion
In summary, Glaukos Corporation (GKOS) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
